TY - JOUR
T1 - The role of location and regional networks for biotechnology firms in Israel
AU - Kaufmann, Dan
AU - Schwartz, Dafna
AU - Frenkel, Amnon
AU - Shefer, Daniel
N1 - Funding Information:
International collaborators Financial support Networking with strategic partners Marketing Available suitable space IPR protection Access to labour pool Management support Legal counselling Connections with suppliers Professional network Access to inputs Strategic counselling Networking of plants Source of technological information Links to financial sources Market information Advanced studies and re-training
Funding Information:
(2) Mapping universities according to their relative strength in biotechnology. This was done by measuring the number of senior staff and the number of students in biotechnology-related fields, including biology, agriculture and medical science (in contrast to medical doctorate studies) (MDs), number of research grants provided by the Israeli Science Foundation and number of patents registered by each institute.
Funding Information:
1. The survey was undertaken as part of the IFISE project conducted under the European Commission 5th framework programme. The survey was conducted in 2001 by Professor D. Shefer and Dr A. Frenkel of the Samuel Neaman Institute for Advanced Studies in Science and Technology, the Technion—Israel Institute of Technology (Shefer & Frenkel, 2003).
PY - 2003/10/1
Y1 - 2003/10/1
N2 - This article presents results of a study of the Israeli biotechnology sector. The findings of the study show that despite the small geographical size of the country, the Israeli biotechnology industry tends to a great extent to cluster around leading research institutes. Based on a survey of 109 high-tech projects, the study suggests that the relatively weak business background of the entrepreneurs, the fact that most of them have worked at research institutes and that most new biotechnology firms were originated from ideas that came out of universities or research institutes, can provide possible explanations for this geographical concentration. The research emphasizes the relative importance biotechnology entrepreneurs ascribe to networking, both in vey early stages as well as in advanced stages of the firm development process. It is argued that although the focus of the network changes over time, both geographically and in content, its links to local research partners are maintained. It is suggested that earmarked regional support policies are crucial to the development of networks required by new biotechnology firms.
AB - This article presents results of a study of the Israeli biotechnology sector. The findings of the study show that despite the small geographical size of the country, the Israeli biotechnology industry tends to a great extent to cluster around leading research institutes. Based on a survey of 109 high-tech projects, the study suggests that the relatively weak business background of the entrepreneurs, the fact that most of them have worked at research institutes and that most new biotechnology firms were originated from ideas that came out of universities or research institutes, can provide possible explanations for this geographical concentration. The research emphasizes the relative importance biotechnology entrepreneurs ascribe to networking, both in vey early stages as well as in advanced stages of the firm development process. It is argued that although the focus of the network changes over time, both geographically and in content, its links to local research partners are maintained. It is suggested that earmarked regional support policies are crucial to the development of networks required by new biotechnology firms.
UR - http://www.scopus.com/inward/record.url?scp=0242583212&partnerID=8YFLogxK
U2 - 10.1080/0965431032000121364
DO - 10.1080/0965431032000121364
M3 - Article
AN - SCOPUS:0242583212
SN - 0965-4313
VL - 11
SP - 823
EP - 840
JO - European Planning Studies
JF - European Planning Studies
IS - 7
ER -